Impact of Surgery on the Development of Duodenal Cancer in Patients with Familial Adenomatous Polyposis
β Scribed by G. Biasco; E. Nobili; C. Calabrese; R. Sassatelli; L. Camellini; M. A. Pantaleo; G. Bertoni; A. De Vivo; M. Ponz De Leon; G. Poggioli; G. Bedogni; T. Venesio; L. Varesco; M. Risio; G. Di Febo; G. Brandi
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 241 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0012-3706
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. Oral sulindac is known to reduce polyps in patients with familial adenomatous polyposis (FAP). The authors speculated that rectal administration of indomethacin would he effective therapy for adenomas in the rectal remnant of FAP. METHODS. Eight patients with FAP who had been treate
## Development of one hundred or more adenomas in the colon and rectum is diagnostic for the dominantly inherited, autosomal disease Familial Adenomatous Polyposis (FAP). It is possible to identify a mutation in the Adenomatous Polyposis Coli (APC) gene in approximately 80% of the patients, and alm